Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB)
ALR Technologies has developed and launched Constant Health Companion™ . This product serves as the communicaton system between the healthcare monitor and the patient. This cutting edge compliance and communication system which employs a modem communication system fills a gap in current health supervision practices by managing medication and treatment compliance for all healthcare entities.
ALR Technologies is a Cost Competitive Alternative
ALR Technologies is competitive in terms of cost. The current pricing is approximately 31% lower than the next closest competitor for 1 year of services and roughly fifty percent lower than the next closest competitor in terms of product price comparisons.
Proven Cost Efficacies
The management of disease medication and treatment compliance is a proven cost effective course of direction in terms of healthcare resources and healthcare dollars. Low rates of medication compliance are viewed by healthcare experts as one of the most serious problems facing medical practitioners. Non-compliance poses a major challenge to effective management of most chronic diseases. About 50% of patients who suffer from chronic diseases are not compliant regarding the taking of medication. Non-compliance is the second largest healthcare issue in the United States in terms of revenue resources consumed.
Vested Interest in Cost Containment
ALR Technologies sells its products directly to disease management companies, pharmaceutical manufacturers, health insurance providers, retail pharmacy chains, and contract research organizations, as well as through distribution companies and to individuals. These entities are attracted by the cost containment for their organizations from proven cost efficacies that result from the use of medication and treatment monitoring devices supported by monitoring programs.
- Health Insurance Payers
- Specialized Pharmacy Services which deal with chronic care patients, such as cancer and organ transplant patients
- Agencies providing care to patients covered by Medicaid, Medicare or other government agencies
- Independent Living Organizations
- Assisted Living Organizations
- Children of elderly parents – direct to consumer placement
Vested Interest in Patient Wellbeing
Families and caretakers have a devotion to the wellbeing of the patient receiving treatment and medication. Adherence to treatment and medication is essential for the patient’s improvement. The monitoring device and associated monitoring programs allow them to intervene and circumvent complications arising from non-compliance. This is elemental and fundamental to providing the best care possible for the patient.
This is a technology which has proven its ability to contribute to the bottom line AND it IS the LOW COST OPTION.
ALR Technologies Power Point Presentation.
Page Minder Report
Source: ALR Technologies
Drug compliance and identity: reasons for non-compliance, Experiences of medication from persons with asthma/allergy. Patient Education and Counseling. Marianne Hansson Scherman and Olle Löwhagen Volume 54, Issue 1 , July 2004, Pages 3-9
Wendy Prabhu, Investor Relations for ALR Technologies, Inc.
Phone: (512) 828-6645
Email: http://www.stockguru.com/blog/alrt@mercomcapital.com
Sidney Chan, CEO
ALRT — ALR Technologies, Inc.
114M Reynolda Village
Winston-Salem, NC 27106
Website: http://www.alrt.com
Phone: (336) 722-2254
SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p
Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/.
Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .